Status:

RECRUITING

REACT - Resistance Exercise After Cancer Treatment

Lead Sponsor:

Inland Norway University of Applied Sciences

Collaborating Sponsors:

Sykehuset Innlandet HF

Conditions:

Cancer

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Resistance exercise has been shown to improve several important health variables after cancer and cancer related treatment, but unfortunately the adherence to resistance exercise is low. Typical repor...

Eligibility Criteria

Inclusion

  • ≥ 18 years and able to give informed consent
  • Previously diagnosed with any form of cancer and completed systemic chemotherapy, immunotherapy or targeted therapies or local radiotherapy
  • Have completed active cancer treatment not more than 12 months earlier or at present undergoing oral home-based treatment for stabilization or other treatments of disease or to prevent relapse
  • Life expectancy of more than 12 months
  • Digital opportunities at home: e.g axcess to pc, and/or ipad, email adress to log on the platform
  • Able to understand Norwegian language

Exclusion

  • Co-morbidities prohibiting exercise according to protocol like serious cardic, pulmonary and other organ diseases
  • Conditions caused by the cancer which prohibits exercise like previous major surgery, fractures, pain
  • Still undergoing active cancer treatment that is expected to confer a high risk of bone marrow suppresion that would lead to infections, bleeding and/or severly reduced physical capacity
  • Life expectancy of less than 12 months
  • Reduced mental capacity and not able to give informed consent and follow the program
  • Travelling distance more than 20 km from home or workplace to the two exercise locations (Gjøvik and/or Lillehammer) for patients who are candidates for randomization

Key Trial Info

Start Date :

August 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2028

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT07159815

Start Date

August 1 2023

End Date

June 30 2028

Last Update

September 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Inland Norway University of Applied Sciences

Lillehammer, Norway